康泰生物：关于更换持续督导保荐代表人的公告

Group 1 - The company, Kangtai Biological, announced a change in the representative for the ongoing supervision of its 2021 convertible bond issuance due to personal work changes of the previous representative [2] - CITIC Construction Investment Securities appointed Mr. Jia Zhe as the new supervising representative effective from February 25, 2026, to ensure the orderly continuation of supervisory duties [2] - The supervision is necessary as the conversion of the bonds to equity has not yet been completed, requiring ongoing oversight and verification [2]